• Rational design and a SAR study of this class of compounds led to a new series of quinazoline derivatives with single-digit nanomolar potency. (northwestern.edu)
  • The present invention relates to a family of S-substituted quinazoline derivatives that inhibitors of the enzyme phosphodiesterase 7 (PDE7), useful for the treatment or prevention of diseases mediated by said enzyme, especially inflammatory, neurodegenerative, neurological, psychiatric and/or autoimmune diseases. (justia.com)
  • The present invention relates to a family of S-substituted quinazoline derivatives that have selective or specific inhibitory activity of the enzyme phosphodiesterase 7 (PDE7), without significantly inhibiting other phosphodiesterases such as the enzyme phosphodiesterase 4 (PDE4). (justia.com)
  • The S-substituted quinazoline derivatives of the present invention are, therefore, useful for the treatment or prevention of diseases mediated by said enzyme PDE7, especially inflammatory, neurodegenerative, neurological, psychiatric and/or autoimmune diseases. (justia.com)
  • The inventors of the present patent, after extensive and exhaustive research, have surprisingly discovered a family of S-substituted quinazoline derivatives that have selective or specific inhibitory activity of the enzyme phosphodiesterase 7 (PDE7), without significantly inhibiting other phosphodiesterases such as the enzyme phosphodiesterase 4 (PDE4). (justia.com)
  • Here we report a novel class of GCase quinazoline inhibitors, obtained in a high throughput screening, with moderate potency against wild-type GCase. (northwestern.edu)
  • c) Organic syntheses of heterocyclic compounds including cofactors, substrates, inhibitors and activators of the above enzymes, as well as relevant detergents and related lipids. (edu.au)
  • An expedient synthesis of oxazepino and oxazocino quinazolines" (PDF). (wikipedia.org)
  • The invention discloses an afatinib refined product synthetic method, and belongs to the technical field of organic synthesis. (lookchem.com)
  • chemistry methods in different research areas, including synthesis. (eurekaselect.com)
  • Patent application PCT WO2008/113881 discloses a family of compounds with a quinazoline nucleus that have dual inhibitory activity of enzymes PDE7 and PDE4 and are useful for the treatment of inflammatory or autoimmune diseases. (justia.com)
  • 4] have shown a synthetic route to a new class of privileged tri- and tetra-cyclic quinazolines containing a medium-sized ring. (wikipedia.org)